UK markets closed
NIKKEI 225
38,073.98 -128.39 (-0.34%) HANG SENG
18,537.81 +223.95 (+1.22%) CRUDE OIL
79.47 +0.48 (+0.61%) GOLD FUTURES
2,342.90 +20.60 (+0.89%) DOW
39,378.25 +321.86 (+0.82%) Bitcoin GBP
49,741.17 +199.76 (+0.40%)
BIO May 2024 260.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:03PM EDT. Market open.
| Previous close | 27.30 |
| Open | 27.30 |
| Bid | 12.30 |
| Ask | 18.90 |
| Strike | 260.00 |
| Expiry date | 2024-05-17 |
| Day's range | 27.30 - 27.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksBio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
Insider MonkeyBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]
- Thomson Reuters StreetEvents
Q1 2024 Bio Rad Laboratories Inc Earnings Call
Q1 2024 Bio Rad Laboratories Inc Earnings Call
© 2024 Yahoo. All rights reserved.